Engagement reflects adoption of industry proven study startup solutions
SAN FRANCISCO, October 17, 2016 -- goBalto, Inc., the leading provider of cloud-based clinical study startup solutions, announced today continued growth in attendance at its biannual Study Startup Summit meetings by leading pharmaceutical and CRO organizations.
The autumn summit, held in Philadelphia, explored how goBalto's award winning suite of study startup applications are continuing to evolve to help clinical research professionals transform their existing business processes, including best practices and case studies. Multiple organizations presented on their goBalto implementations, results and key learnings to further enhance study startup optimization.
goBalto's Study Startup Summit far exceeded my expectations. Not only was I able to gain valuable insight from listening to the experiences of other clients, but I was also able to gain a clear view of goBalto's direction and the possibilities their goals will create for my company's study startup business needs," stated Jennifer Evola, Senior Regulatory Documents Specialist, Allergan.
goBalto's CEO, Sujay Jadhav, opened the summit with a keynote address highlighting the industry trends in study startup, growing market adoption by the industry, evolution of goBalto's study startup platform and future technology vision.
"Our industry proven end-to-end study startup methodology, spanning site identification, feasibility assessment, selection through to activation, with comprehensive metrics, aligns with the goal of faster development by significantly impacting cycle times," said Jadhav. "This leads to greater cost savings, mitigates rescue studies, and leads to faster market entry. Ultimately, achieving the goal of speeding the delivery of valuable therapies to patients sooner."
With recent multiple enterprise and global expansions goBalto now services three of the top five CROs and more than two-thirds of the top 25 pharmas, managing their clinical trial documents globally, representing more than 85 percent of clinical trial sites in phase II & III of the top 20 pharma companies.
Christine Pierre, President of the Society for Clinical Research Sites (SCRS) and industry keynote speaker at the goBalto Study Startup Summit, stated, "Investigative sites are the lifeblood of clinical trials. As such, the deployment of technology that can help sites facilitate collaboration and communications with sponsors and CROs is critical. It is pleasing to see the evolution of tools that continue to enhance and streamline this effort."
With over 35,000 investigative sites in more than 60 countries using goBalto Activate, the company's flagship product, to manage, track, and complete study startup tasks, goBalto has the largest industry-proven set of country specific regulatory business process workflows.
According to Jadhav, "The maturity of our solution is having a significant impact, delivering tangible operating results, allowing companies to dramatically improve their study startup operations. Multiple customers including global CROs and large multinational pharmaceutical companies have reported an over 30 percent reduction in cycle time for sites managed in Activate. We are the only vendor capable of delivering consistent cycle time savings, and it is this field tested validation that customers are seeking."
Registration for the goBalto Study Startup Summit is complimentary for goBalto customers and invited guests. To learn more or register for the spring summit to be held in New York, March 8 - 9, please contact us.